VantEdge Access delivers pragmatic market access and reimbursement advisory services for biopharma accelerated by OMNIA, our value intelligence platform analyzing 10k+ payer decisions across USA, Canada, Europe, Latin America, and Australia.

Our mission: accelerate patient access by combining 100+ years of pharmaceutical leadership with AI-driven evidence generation and reimbursement strategy, delivering actionable insights to support strategic milestone decisions.

What Makes Us Different: We deliver practical recommendations in today's fast-moving healthcare environment. OMNIA analyzes global payer decisions, pricing precedents, and value frameworks enabling evidence-backed reimbursement recommendations. Our experience launching biologics, rare disease therapies, and gene therapies globally sets us apart.

Our Services:

• Early-Stage (Phase 2-3): TPP Optimization, Commercial Assessment, Value Story Development

• Launch-Stage: Pricing & Reimbursement Strategy, Payer Evidence Plans, Value Dossiers, Global Access Planning

• All Stages: Financial Analysis, Competitive Intelligence, Health Economics Modeling, Real-World Evidence Strategy

How We Work: OMNIA-powered intelligence reports delivered in days, backed with strategic market access and pricing consultation, and retainer advisory for continuous support (fractional Chief Access Officer, Value & Access Lead).

Who We Serve: Biopharma developing therapies in all therapeutic areas, from Phase 2 to products securing reimbursement.

Our Technology Edge: OMNIA combines AI-powered payer analysis with value frameworks, enabling faster pricing and reimbursement strategies. The platform accelerates research, not replaces thinking.

Our Team: Senior advisors from leading pharmaceutical companies bring payer negotiation, value demonstration, and regulatory expertise.

Your trusted, long-term strategic partner for market access from development through commercialization.

contact@vantedgeaccess.com | vantedgeaccess.com

VantEdgeAccess

Org chart

Teams

Offices